[
  {
    "ts": null,
    "headline": "Analysts consider potential Qiagen deal amid reported strategic review",
    "summary": "Investing.com -- Shares of Qiagen NV (NYSE:QGEN) surged 16% this week after a Bloomberg report on Tuesday said the company was exploring a potential sale amid renewed interest from several global strategic buyers. The news sparked an immediate rally in the stock, as investors priced in a long-awaited consolidation. Analysts across Wall Street weighed in on the potential sale of the mid-cap diagnostics firm, following years of speculation about its future. Following the news, JPMorgan analyst Cas",
    "url": "https://finnhub.io/api/news?id=3ce525426bcb6c73411553e31da5b7f74d1bbc32ce12bd58483f8d189b158a94",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769203201,
      "headline": "Analysts consider potential Qiagen deal amid reported strategic review",
      "id": 138229361,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "A",
      "source": "Yahoo",
      "summary": "Investing.com -- Shares of Qiagen NV (NYSE:QGEN) surged 16% this week after a Bloomberg report on Tuesday said the company was exploring a potential sale amid renewed interest from several global strategic buyers. The news sparked an immediate rally in the stock, as investors priced in a long-awaited consolidation. Analysts across Wall Street weighed in on the potential sale of the mid-cap diagnostics firm, following years of speculation about its future. Following the news, JPMorgan analyst Cas",
      "url": "https://finnhub.io/api/news?id=3ce525426bcb6c73411553e31da5b7f74d1bbc32ce12bd58483f8d189b158a94"
    }
  },
  {
    "ts": null,
    "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of Jan 25",
    "summary": "A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read the full list here.",
    "url": "https://finnhub.io/api/news?id=51cad26e98a55cff634e728377ee94ee04cf1e5384eb442f6922079bdc07e397",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769191913,
      "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of Jan 25",
      "id": 138229764,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
      "related": "A",
      "source": "SeekingAlpha",
      "summary": "A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read the full list here.",
      "url": "https://finnhub.io/api/news?id=51cad26e98a55cff634e728377ee94ee04cf1e5384eb442f6922079bdc07e397"
    }
  },
  {
    "ts": null,
    "headline": "Agilent Technologies Inc. stock underperforms Friday when compared to competitors",
    "summary": "Agilent Technologies Inc. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=422716cfdeb9564f36c388a27d4b21d5648ac98923bf505d9461354e59ac4ac6",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769187120,
      "headline": "Agilent Technologies Inc. stock underperforms Friday when compared to competitors",
      "id": 138242361,
      "image": "",
      "related": "A",
      "source": "MarketWatch",
      "summary": "Agilent Technologies Inc. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=422716cfdeb9564f36c388a27d4b21d5648ac98923bf505d9461354e59ac4ac6"
    }
  },
  {
    "ts": null,
    "headline": "PBH vs. A: Which Stock Is the Better Value Option?",
    "summary": "PBH vs. A: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=c8c48685a8ab3acd00a005c66bc8f6d550225360e257cb25cae4ecd5c71c0dd1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769186403,
      "headline": "PBH vs. A: Which Stock Is the Better Value Option?",
      "id": 138228628,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "A",
      "source": "Yahoo",
      "summary": "PBH vs. A: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=c8c48685a8ab3acd00a005c66bc8f6d550225360e257cb25cae4ecd5c71c0dd1"
    }
  },
  {
    "ts": null,
    "headline": "Agilent Accelerates Digital Pathology with the Launch of the Agilent S540MD Slide Scanner System",
    "summary": "SANTA CLARA, Calif., January 23, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent S540MD Slide Scanner System, a whole slide imaging (WSI) digital scanner, available for sale in key European markets. The launch reflects Agilent’s continued investment in digital pathology, expanding its portfolio to meet the growing demand for high-throughput solutions in clinical laboratories.",
    "url": "https://finnhub.io/api/news?id=8d9b9bd68fdcf155e53fa4af13745d58d86301c30e24bc8f4ea23317682fb8da",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769173200,
      "headline": "Agilent Accelerates Digital Pathology with the Launch of the Agilent S540MD Slide Scanner System",
      "id": 138224908,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "A",
      "source": "Yahoo",
      "summary": "SANTA CLARA, Calif., January 23, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent S540MD Slide Scanner System, a whole slide imaging (WSI) digital scanner, available for sale in key European markets. The launch reflects Agilent’s continued investment in digital pathology, expanding its portfolio to meet the growing demand for high-throughput solutions in clinical laboratories.",
      "url": "https://finnhub.io/api/news?id=8d9b9bd68fdcf155e53fa4af13745d58d86301c30e24bc8f4ea23317682fb8da"
    }
  },
  {
    "ts": null,
    "headline": "Omics Lab Services: Global Market Review 2021-2025 and Forecast 2026-2031 Featuring Profiles of Agilent Technologies, Q2 Solutions, Flomics Biotech, QIAGEN, Thermo Fisher Scientific and More",
    "summary": "Key growth drivers include the rising shift towards personalized medicine and the demand for non-invasive diagnostics, particularly in oncology Omics Lab Services Market Omics Lab Services Market Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The \"Omics Lab Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031\" has been added to ResearchAndMarkets.com's offering.The Global Omics Lab Services Market is projected to expand from USD 72.88 Billion in 2025 to USD 128.",
    "url": "https://finnhub.io/api/news?id=810f7725795612b5e57f2dfc12a9ddf09d4bf91f536516368476d7ebd3803ced",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769168100,
      "headline": "Omics Lab Services: Global Market Review 2021-2025 and Forecast 2026-2031 Featuring Profiles of Agilent Technologies, Q2 Solutions, Flomics Biotech, QIAGEN, Thermo Fisher Scientific and More",
      "id": 138223457,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "A",
      "source": "Yahoo",
      "summary": "Key growth drivers include the rising shift towards personalized medicine and the demand for non-invasive diagnostics, particularly in oncology Omics Lab Services Market Omics Lab Services Market Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The \"Omics Lab Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031\" has been added to ResearchAndMarkets.com's offering.The Global Omics Lab Services Market is projected to expand from USD 72.88 Billion in 2025 to USD 128.",
      "url": "https://finnhub.io/api/news?id=810f7725795612b5e57f2dfc12a9ddf09d4bf91f536516368476d7ebd3803ced"
    }
  }
]